Literature DB >> 8003677

Enhanced alpha-2 adrenergic controls and spinal morphine potency in inflammation.

L C Stanfa1, A H Dickenson.   

Abstract

The antinociceptive potency of spinal morphine is enhanced in rats after carrageenan-induced inflammation. This electrophysiological study examines whether changes in alpha-2 adrenergic systems are responsible. Dorsal horn nociceptive neurones were recorded under halothane anaesthesia in normal animals and animals with carrageenan inflammation. There was a mild increase in potency of the selective alpha-2 adrenoceptor agonist dexmedetomidine following carrageenan (ED50 = 1 microgram). Intrathecal idazoxan (100 micrograms), an alpha-2 antagonist, produced a significant facilitation of the C-fibre evoked response in carrageenan-treated but not normal animals. However since neither idazoxan (100 micrograms) or atipamezole (50 micrograms, another antagonist) influenced the potency of spinal morphine, the increased alpha-2 adrenergic activity in inflammation does not contribute to the enhanced potency of spinal morphine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8003677     DOI: 10.1097/00001756-199401120-00025

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  4 in total

1.  Chapter 9 The dorsal horn and hyperalgesia.

Authors:  Karin N Westlund
Journal:  Handb Clin Neurol       Date:  2006

Review 2.  Neuroanatomy of the pain system and of the pathways that modulate pain.

Authors:  W D Willis; K N Westlund
Journal:  J Clin Neurophysiol       Date:  1997-01       Impact factor: 2.177

Review 3.  Spinal opioid systems in inflammation.

Authors:  L Stanfa; A Dickenson
Journal:  Inflamm Res       Date:  1995-06       Impact factor: 4.575

4.  Serotonin receptors are involved in the spinal mediation of descending facilitation of surgical incision-induced increase of Fos-like immunoreactivity in rats.

Authors:  João Walter S Silveira; Quintino M Dias; Elaine A Del Bel; Wiliam A Prado
Journal:  Mol Pain       Date:  2010-03-23       Impact factor: 3.395

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.